Your session is about to expire
← Back to Search
Healthy patients for Functional Abdominal Bloating
N/A
Recruiting
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-4 years
Awards & highlights
Study Summary
We will sample intestinal microbiota using a microbiome sampling capsule in Healthy, Irritable Bowel Syndrome (IBS), and Functional Gastrointestinal Disease.
Eligible Conditions
- Functional Abdominal Bloating
- Healthy Subjects
- Functional Gastrointestinal Disorders
- Irritable Bowel Syndrome
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1-4 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-4 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Collection of 50ul of intestinal fluid from >90% of microbiome sampling capsules
Secondary outcome measures
Isolation of liven bacteria from the intestinal fluid of >90% of microbiome sampling capsules
Trial Design
2Treatment groups
Experimental Treatment
Group I: IBS/Functional GI diaseaseExperimental Treatment1 Intervention
Patients with IBS or Functional GI disease (bloating, diarrhea, constipation)
Group II: Healthy patientsExperimental Treatment1 Intervention
Healthy Patients
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,387 Previous Clinical Trials
17,334,010 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger